Early Lymph Node Metastasis in T1/2 Stage Colorectal Cancer: Molecular and Clinical Insights
NCT06130644 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1451
Last updated 2023-11-14
Summary
The prognostic implications of lymph node metastasis in colorectal cancer patients at an early stage, specifically T1/2 stage, are relatively unfavorable. Therefore, understanding the clinical and molecular traits relevant to metastasis in T1/2 stage are of substantial clinical importance.
Conditions
Sponsors & Collaborators
-
The First Affiliated Hospital with Nanjing Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-01
- Primary Completion
- 2022-12-31
- Completion
- 2022-12-31
More Related Trials
-
Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis
NCT02979795 ·Status: UNKNOWN
-
Clinical Relevance of Major Pathologic Regression for Locally Advanced Rectal Cancer
NCT06879197 ·Status: COMPLETED
-
Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer
NCT06040021 ·Status: COMPLETED
-
Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer
NCT06614660 ·Status: ACTIVE_NOT_RECRUITING
-
Endoscopic Ultrasound Predict the Sensitivity of Stage II / III Rectal Cancer Preoperative Concurrent Chemoradiotherapy
NCT01582750 ·Status: UNKNOWN
-
Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer
NCT05414461 ·Status: COMPLETED ·Phase: PHASE2
-
Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis
NCT04714814 ·Status: UNKNOWN
-
Impact of Body Mass Index and Lipid Metabolism on Anti-PD-1 Immunotherapy Outcomes in Colorectal Cancer
NCT07012174 ·Status: COMPLETED
-
The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer
NCT03794193 ·Status: UNKNOWN
-
Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis
NCT03149978 ·Status: UNKNOWN
-
Study of Biomarkers in Tissue Samples From Patients With Metastatic Colon Cancer
NCT01012804 ·Status: WITHDRAWN
-
Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer
NCT07269912 ·Status: NOT_YET_RECRUITING
-
Study of Intramural Spread Pattern in Low Rectal Cancer.
NCT07202169 ·Status: COMPLETED
-
CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC
NCT03725254 ·Status: UNKNOWN ·Phase: PHASE2
-
Surgery Following Immune Checkpoint Inhibitions for Controlled Disease in Recurrent or Metastatic dMMR/MSI-H Colorectal Cancer
NCT06717763 ·Status: COMPLETED
-
PET on Surgery for Loco-regionally Recurrent Colorectal Cancer
NCT05924282 ·Status: COMPLETED
-
Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM
NCT05129774 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Genomic Signatures for Patients With Initially Unresectable Colorectal Liver Metastases
NCT06477718 ·Status: COMPLETED
-
Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral Resection
NCT06115837 ·Status: COMPLETED
-
Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer
NCT06114420 ·Status: RECRUITING
-
The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer
NCT02523495 ·Status: UNKNOWN
-
Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer
NCT06858956 ·Status: NOT_YET_RECRUITING
-
In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk Factors
NCT06185907 ·Status: COMPLETED
-
PET-CT and Circulating Tumor Cells in Colorectal Cancer
NCT01163305 ·Status: COMPLETED
-
The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival
NCT04482608 ·Status: COMPLETED